Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T

被引:136
作者
Cheng, LL
Wu, CL
Smith, MR
Gonzalez, RG
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Pathol, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Hematol & Oncol, Boston, MA 02114 USA
[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiol, Boston, MA 02114 USA
关键词
human prostate; spermine; proton nuclear magnetic resonance spectroscopy; high resolution magic angle spinning; intact tissue specimen; citrate;
D O I
10.1016/S0014-5793(01)02329-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We present the results of a study of human prostate specimens evaluated by high resolution magic angle spinning H-1 nuclear magnetic resonance (NMR) spectroscopy at 400 MHz (9.4 T) and by quantitative histopathology, We demonstrate that NMR and pathology data can be obtained from the same intact specimens, and report for the first time a linear correlation between the NMR measured concentration of spermine, a proposed endogenous inhibitor to prostate cancer growth, and the volume percentage of normal prostatic epithelial cells as quantified by histopathology, Our results show that NMR may serve as a critical tool for the investigation of the inhibitory mechanism of spermine in human subjects. (C) 2001 Published by Elsevier Science B,V, on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:112 / 116
页数:5
相关论文
共 20 条
[1]  
Cheng LL, 2000, NEURO-ONCOLOGY, V2, P87, DOI 10.1093/neuonc/2.2.87
[2]   Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning [J].
Cheng, LL ;
Lean, CL ;
Bogdanova, A ;
Wright, SC ;
Ackerman, JL ;
Brady, TJ ;
Garrido, L .
MAGNETIC RESONANCE IN MEDICINE, 1996, 36 (05) :653-658
[3]   IN-VITRO PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF 4 HUMAN PROSTATE-CANCER CELL-LINES [J].
CORNEL, EB ;
SMITS, GAHJ ;
DERUIJTER, JE ;
OOSTERHOF, GON ;
HEERSCHAP, A ;
DEBRUYNE, FMJ ;
SCHALKEN, JA .
PROSTATE, 1995, 26 (05) :275-280
[4]  
Costello LC, 1999, PROSTATE, V38, P237, DOI 10.1002/(SICI)1097-0045(19990215)38:3<237::AID-PROS8>3.0.CO
[5]  
2-O
[6]  
Degeorges A, 1996, INT J CANCER, V68, P207, DOI 10.1002/(SICI)1097-0215(19961009)68:2<207::AID-IJC12>3.0.CO
[7]  
2-7
[8]  
Gately S, 1996, CANCER RES, V56, P4887
[9]  
Hahn P, 1997, CANCER RES, V57, P3398
[10]  
Lynch MJ, 1997, PROSTATE, V30, P248